Synthetic strategy develops antibacterial polymer nanotubes with regenerable chlorine for enhanced efficacy against bacteria.
Bacteria pose significant threats to human health, industrial production, and daily life, with widespread microbial contamination remaining a critical challenge for global public health. Conventional porous materials often suffer from insufficient antibacterial efficacy, necessitating the development of advanced antimicrobial systems. Herein, we report a synthetic strategy for fabricating chloride-regenerable porous tubular polymers (HCP-DMH-Cl) via a combination of Friedel–Crafts alkylation and nucleophilic substitution reactions. HCP was initially prepared through a crosslinking reaction via Friedel–Crafts alkylation using FeCl3 as the catalyst and benzyl alcohol as the monomer. SEM characterization was performed to validate the tubular architectural morphology of HCP. The polymeric N-halamine precursor, HCP-DMH, was subsequently obtained through stepwise bromomethylation and nucleophilic substitution modifications. Upon chlorination, HCP-DMH-Cl exhibited good antibacterial efficacy against both E. coli and S. aureus, coupled with favorable regenerability of its oxidative chlorine content. This approach paves the way for designing next-generation porous media with tailored antibacterial functionality and sustainable chlorine-release capabilities.
No takes yet. Share an insight, caveat, or question.
Mao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: